Clinical Trial Update: A Comparison of Methylphenidate and Cognitive Behavioural Therapy for the Treatment of Binge Eating Disorder [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial comparing methylphenidate to cognitive behavioral therapy for binge eating disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Binge Eating Disorder

Drugs mentioned

• Methylphenidate (Methylphenidate)

Snippet

Sponsor: Centre for Addiction and Mental Health | Conditions: Binge-Eating Disorder | Phase 2 | Status: COMPLETED